Request Sample
Request Methodology
Description
The global genome engineering market is anticipated to grow from USD 5.1 billion to USD 11.2 billion till the forecasting year 2025 and grow at a CAGR of 17.0 during the period of fore
Market Outline:
Genome engineering is a therapy used for the modification, insertion and deletion of DNA bases in living being. Ex-Vivo Gene and In-Vivo Gene are the two kinds of therapies available. The aim behind doing genome engineering is to treat different diseases and doing research. It is also used for biotechnological purpose too. This therapy is also used for cutting DNA chains to add or remove the DNA in the genome. Important techniques employed in genome engineering include ZFN, CRISPR and TALEN. Such effective genome engineering tools greatly help researchers for editing parts of the genome with adding, removing and changing the sections of the DNA sequence. CRISPR is an affordable, rapid and precise tool used rather than other tools to edit DNA. Genome engineering therapy involves understanding the role of particular genes. This therapy also involves understanding the processes of organ specific stem cells like stem cells like spermatogonial stem cells and neutral stem cells. Different types of cancers, Agents of infectious sicknesses like parasites, viruses, bacteria and genetically affected cells are treated with genome editing.
Driving and restraining factors
There are many prominent elements that contribute in driving the genome engineering market such as increasing occurrence of genetic disorders, increasing number of genetically modified crops production, increasing developments for genome engineering therapy and rise in funding for genome engineering. The genome engineering market is increasing hugely due to the use of genome technique in several different areas like agriculture biotechnology, mutation and therapeutics. Increase in the number of sicknesses and applications of genome editing lead towards increasing the scope for genome engineering in upcoming years. A few factors contribute to restrain the market growth such as stringent regulation and the perception of the people for genetic alteration. Genome editing therapies provide a huge range of opportunities in crop investment.
Homologous recombination is anticipated to be utilized as an efficient technology for crop improvement. Increase in the number of genomics projects and government funding facilities will drive the market growth. High price of genome engineering therapies is anticipated to hit the growth of genome engineering market during the forecast period particularly in rising countries such as South Africa, India and Brazil. This therapy involves using a complex technology and requires expert researchers, which in turn limit the market growth
Market Players operating in Genome Engineering Market
- CRISPR Therapeutics,
- Thermo Fisher Scientific
- GenScript Corporation
- Sangamo Therapeutics, Inc
- Horizon Discovery Group
- Integrated DNA Technologies
- New England Biolabs
- OriGene Technologies
- Lonza Group
- Editas Medicine
Several notable development are observed in the genome engineering market as companies have adopted crucial strategies like collaboration, partnership, agreement and acquisition. Key players have also adopted some crucial strategies like approvals, product expansion and product launch, which allows them to maintain their position in the market and also increase their overall customer base.
Global Genome Editing Market Segmentation:
Based on Application
- Cell Line Engineering
- Genetic Engineering
- Others
Based on End-user
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
Based on Region
Asia Pacific
-
- Japan
- India
- China
Middle East and Africa
-
- South Africa
- Saudi Arabia
- UAE
South and Central America
-
- Brazil
- Argentina
Based on Technology
- CRISPR
- ZFNs
- TALENS
- Others
Growth factors driving the genome editing market in upcoming days are increase in funds by government in different regions, government support for the academic institutes to increase research activities for genome editing and huge increase in funding. Increasing cancer cases, growth of pharmaceutical companies, fast advancements and increase in public sector funding are some significant factors boost the genome engineering market
Location
GEOGRAPHY
